Rare diseases
Investigational molecules
Locations
Back to Bulgaria57 clinical trials in Dupnitsa, Bulgaria. Every trial is listed in the EU Clinical Trials Register and updated daily.
A Phase III Randomized Double‑Blind Study of Elecoglipron for Adults with Type 2 Diabetes on Insulin
BulgariaA study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria
BulgariaA study to evaluate the effectiveness and safety of ritlecitinib tosilate and loratadine in adults with chronic spontaneous urticaria (hives)
BulgariaStudy of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo
BulgariaStudy of AZD6793 tablets to reduce flare-ups in adults with moderate to very severe chronic obstructive pulmonary disease (COPD)
BulgariaLong-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials
BulgariaStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
BulgariaStudy on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure
BulgariaStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)
BulgariaStudy of Three Doses of Frevecitinib (KN-002) in Adults with Severe Asthma Not Controlled by Medium‑to‑High Dose Inhaled Steroid/LABA Therapy
BulgariaRandomized trial of elecoglipron with dapagliflozin versus placebo in adults with type 2 diabetes mellitus and impaired renal function
BulgariaEffect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on cardiovascular health and metabolic conditions, including studies of new treatments for obesity and heart conditions. Research aims to evaluate therapies for reducing cardiovascular risks and managing weight-related health issues.
Current studies are examining novel compounds for cardiovascular safety and weight reduction outcomes.
Advanced research in respiratory diseases, particularly focusing on chronic conditions affecting lung function. Studies evaluate new treatment combinations and their impact on patient outcomes.
Trials are investigating innovative therapies to prevent lung function decline and manage exacerbations.
Comprehensive research in dermatological conditions, investigating new treatments for various skin disorders. Studies focus on both chronic and acute skin conditions.
Evaluating long-term safety and efficacy of novel therapeutic approaches for skin disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
